d-alpha tocopherol has been researched along with ergothioneine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aruoma, OI; Bonet, B; Guijarro, MV; Indart, A; Viana, M | 1 |
| Aruoma, OI; Assunta Dessì, M; Casu, V; Deiana, M; Piga, R; Rosa, A | 1 |
| Dolcet, X; Encinas, M; Eritja, N; Llobet, D; Llombart-Cussac, A; Marti, RM; Matias-Guiu, X; Schoenenberger, JA; Sorolla, A; Yeramian, A | 1 |
| Hondal, RJ | 1 |
1 review(s) available for d-alpha tocopherol and ergothioneine
| Article | Year |
|---|---|
Selenium vitaminology: The connection between selenium, vitamin C, vitamin E, and ergothioneine.
Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; Ergothioneine; Free Radicals; Lipid Peroxides; Oxidation-Reduction; Selenium; Selenocysteine; Thioredoxin-Disulfide Reductase; Vitamin E; Vitamins | 2023 |
3 other study(ies) available for d-alpha tocopherol and ergothioneine
| Article | Year |
|---|---|
Effects of ergothioneine on diabetic embryopathy in pregnant rats.
Topics: Animals; Antioxidants; Blood Glucose; Congenital Abnormalities; Diabetes Mellitus, Experimental; Embryonic and Fetal Development; Ergothioneine; Female; Neural Tube Defects; Pregnancy; Pregnancy in Diabetics; Pregnancy Outcome; Rats; Rats, Wistar; Vitamin E | 2002 |
L-ergothioneine modulates oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of polyunsaturated fatty acids.
Topics: alpha-Tocopherol; Animals; Antioxidants; Chromatography, High Pressure Liquid; Ergothioneine; Fatty Acids, Unsaturated; Ferric Compounds; Glutathione; Kidney; Lipids; Liver; Male; Nitrilotriacetic Acid; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar | 2004 |
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.
Topics: Antioxidants; Antipyrine; Apoptosis; Ascorbic Acid; Blotting, Western; Boronic Acids; Bortezomib; Butylated Hydroxyanisole; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Coumarins; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Edaravone; Endometrial Neoplasms; Ergothioneine; Female; Humans; Leupeptins; Oligopeptides; Proteasome Inhibitors; Pyrazines; Ubiquitin; Vitamin E; Vitamins | 2008 |